[144] nLIGHT, Inc. SEC Filing
Form 144 notice for nLIGHT, Inc. (LASR): An insider proposes to sell 17,018 common shares through Fidelity Brokerage with an aggregate market value of $482,073.99, targeting an approximate sale date of 08/22/2025 on NASDAQ. The shares were acquired on 08/20/2025 upon restricted stock vesting and the payment type is listed as compensation. The filing reports total shares outstanding of 49,899,461. The document also lists multiple prior common-share sales by Scott H. Keeney during May–August 2025 with specific quantities and gross proceeds.
- Transaction arose from restricted stock vesting, indicating this is a compensation-related disposition rather than an external liquidation.
- Filing specifies broker, share amounts, and aggregate value, providing clear disclosure for market participants.
- Multiple insider sales by the same individual (Scott H. Keeney) in the prior three months are reported, which may attract investor attention.
- Filing does not state a 10b5-1 trading plan adoption date, so it is unclear whether sales were pre-scheduled under an affirmative defense.
Insights
TL;DR: Routine insider sale following equity vesting; aggregate value is modest relative to total shares outstanding.
The filing documents a proposed sale of 17,018 common shares (acquired via restricted stock vesting on 08/20/2025) for $482,073.99, to be executed through Fidelity on 08/22/2025. The transaction is recorded as compensation-related and does not disclose any material nonpublic information. Reported outstanding shares are 49,899,461, which places this sale at roughly 0.034% of outstanding common shares, indicating a non-control, routine disposition.
TL;DR: Disclosure is consistent with Rule 144 reporting; multiple recent insider sales are documented but no additional context is provided.
The Form 144 follows required reporting for proposed sales. The filer attests there is no undisclosed material adverse information. The schedule of recent sales by Scott H. Keeney across May–August 2025 provides transparency about past dispositions. The filing does not include any statements about a trading plan or 10b5-1 adoption date, so readers cannot confirm whether sales were pre-planned under an affirmative defense.